Galvumet 50/500
Galvumet 50/500 is a medicine authorised by Swissmedic under authorisation number 58451. The authorisation holder is Novartis Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 06 November 2009 and the authorisation is valid without a time limit. ATC code A10BD08 places the medicine in the group Drugs used in diabetes.
| Authorisation number | 58451 |
|---|---|
| Name | Galvumet 50/500 |
| Full name | Galvumet 50/500, Filmtabletten |
| Authorisation holder | Novartis Pharma Schweiz AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | A10BD08 |
| First authorisation | 06 November 2009 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Galvumet 50/500, Filmtabletten | B | 06 November 2009 |
| 2 | Galvumet 50/850, Filmtabletten | B | 06 November 2009 |
| 3 | Galvumet 50/1000, Filmtabletten | B | 06 November 2009 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 2 | 60 | Tablette(n) | A10BD08 | 07.06.2. | B |
| 7 | 180 | Tablette(n) | A10BD08 | 07.06.2. | B |
| 4 | 60 | Tablette(n) | A10BD08 | 07.06.2. | B |
| 8 | 180 | Tablette(n) | A10BD08 | 07.06.2. | B |
| 6 | 60 | Tablette(n) | A10BD08 | 07.06.2. | B |
| 9 | 180 | Tablette(n) | A10BD08 | 07.06.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Galvumet 50/500 authorised in Switzerland?
Yes. Galvumet 50/500 is authorised by Swissmedic under authorisation number 58451, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Galvumet 50/500 have?
Galvumet 50/500 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Galvumet 50/500?
The authorisation holder is Novartis Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.